1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. PANACEA BIOTEC LTD.
Panacea Biotec Ltd.
NSE: PANACEABIO | BSE: 531349
Clinical TrialsPatent Approvals
Ask AI about Panacea Biotec
356.553.85(1.09%)
131.6K
NSE+BSE Volume

High vol. this week

NSE 18 Nov, 2026 3:31 PM

Portfolio

Alert

My Notes

Panacea Biotec quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Panacea Biotec quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Panacea Biotec Sep-2026 Quarterly Revenue is Rs 133 Cr which is growth of 41.0% YoY.

  • POSITIVE

    Quarterly Net Profit Panacea Biotec Sep-2026 Quarterly Net Profit is Rs 11 Cr which is growth of 168.7% YoY.

Panacea Biotec Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23
⌄
133.1140.8116.7103.294.4117.274111.880.160.796.898.396.7
Operating Exp.
108.2127.4110.8100.7104.5115.386.59369.967.489.688.684.6
Operating Profit
18.57.30.3-1.4-13.7-3-18.615.46.7-10.5-9.26.610
Operating Profit Margin %
14.60%5.42%0.27%-1.39%-15.09%-2.69%-27.35%14.19%8.79%-18.44%-11.50%6.97%10.53%
Depr.
4.54.54.24.94.94.84.95.25.15.15.15.25.3
Interest
6.36.96.375.964.63.93.83.23.43.43.6
Profit Before Tax
14.12-4.6-9.5-20.9-8.8-229.71.3-15-1.41.13.2
Tax
3.30.6-4.4-2.1-5.3-2.1-9.60-1.200.6
Net Profit
10.81.4-0.2-7.4-15.6-6.7-12.49.71.3-13.8-1.40.43.2
EPS Adj. latest
1.80.2-0-1.2-2.6-1.1-21.60.2-2.3-0.20.10.5
Net profit TTM
4.6-21.8-29.9-42.1-25.1-8.2-15.2-4.2-13.4-11.53.6-14.8-2
Basic EPS TTM
0.8-3.6-4.9-6.9-4.1-1.3-2.5-0.7-2.2-1.90.6-2.4-0.3
Results PDF
Result Notes
 
*All financials are in INR Cr and price data in INR

Panacea Biotec competitor comparison and performance snapshot within industry

Panacea Biotec revenue mix: sales, profit, and capital employed breakups by segment

Panacea Biotec annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

  • POSITIVE

    Annual Revenue Panacea Biotec Mar-2026 Annual Revenue is Rs 431 Cr which is growth of 32.2% YoY.

  • NEGATIVE

    Annual Net Profit Panacea Biotec Mar-2026 Annual Net Profit is Rs -30 Cr which is growth of -96.4% YoY.

Panacea Biotec Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
14%
3.4%
493.7431.5326.5384.5291.5248.1364.318999.7196.2583.8672.5
Operating Exp. Ann.
10.5%
4.7%
447.1431.3316.8345.4319.7308.2343.1220.3242.9191.8460.6534.4
Operating Profit Ann.
-
-
24.7-17.8-6.914.2-62.6-72.70.5-62.2-146.7-8.169.5112.5
OPM Ann. %
-
-
 -4.13%-2.12%3.68%-21.48%-29.29%0.13%-32.93%-147.05%-4.13%11.90%16.73%
⌄
10.3%
4.7%
 475.4352.5380.3354.3341.7377.2252.5380.5328.7630.3720.7
EBITDA Ann.
-
-60.7%
 0.29.739.1-28.2-60.121.2-31.4-143.14.4123.2138.1
EBITDA Ann. margin %
-
-63.1%
 0.04%2.97%10.16%-9.67%-24.23%5.83%-16.59%-143.52%2.24%21.10%20.53%
Interest Ann.
35.8%
27.5%
26.625.315.513.810.177.55.3104.6103.2103.5115
Depr.
-8.6%
-6.8%
18.118.720.321.124.526.426.626.93333.766.271.3
PBT Ann.
-
-
2-43.9-26.14.2-62.8-93.6-12.9-78.932.6-132.5-841.4
Tax Ann.
-
-
-2.6-14-10.80.724.81.617.110.610.6-11.40.5
-
-
 -29.9-15.23.6-87.5-93.6-14.4-9621.9-143.2-72.70.9
Net Profit Ann.
-
-
4.6-29.9-15.23.6-87.5-93.6-14.4-153.126.6-71.9-72.70.9
NPM Ann. %
-
-
 -7.23%-4.91%0.98%-34.05%-39.73%-4.20%-96.82%27.61%-39.12%-13.70%0.13%
EPS Adj. latest Ann.
-
-
 -4.9-2.50.6-14.3-15.3-2.4-254.3-11.7-11.90.1
Result Notes
   
Annual Reports
 
*All financials are in INR Cr and price data in INR
Total Rev. Ann.
1Y CHG
32.2%
2Y CAGR
5.9%
3Y CAGR
14%
5Y CAGR
3.4%
7Y CAGR
23.3%
10Y CAGR
-4.3%
Total Revenue Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
36.1%
2Y CAGR
11.7%
3Y CAGR
10.5%
5Y CAGR
4.7%
7Y CAGR
8.5%
10Y CAGR
-2.1%
Operating Expenses Annual Cr growth is higher than historical averages.

Panacea Biotec balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund Panacea Biotec Mar-2026 Total Shareholders Fund is Rs 264 Cr which is growth of -12.0% YoY.

  • NEGATIVE

    Total Assets Panacea Biotec Mar-2026 Total Assets is Rs 852 Cr which is growth of -2.0% YoY.

Panacea Biotec Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
⌄
-5.2%
-11.7%
263.6299.5313.5309397.6490873.8419.4387.9454.7540
Minority Interest Liability Ann.
-
-
-----------
⌄
26.2%
28.9%
282196.9169.5140.395.879.272.291.9590.7727.5793.4
4.1%
7.3%
285.2351.4249253246.8200.8170.6921.1685.3589.9474
Total Capital Plus Liabilities Ann.
5.6%
1.5%
852.4869.5753.6723.9761.8791.61,138.51,4421,673.51,781.81,807.4
⌄
5.8%
2.8%
548.7535.3519.6463.2454.9477.2503499.5928.1969.71,006.6
⌄
3.1%
2.6%
567.9575.7570.4518.8473499524.2525.91,319.81,372.41,468.6
11.5%
-0.6%
284.5293.7183.2205.1288.8292.6614.3916.1353.7409.4338.8
Total Assets Ann.
5.6%
1.5%
852.4869.5753.6723.9761.8791.61,138.51,4421,673.51,781.81,807.4
Contingent Liabilities plus Commitments Ann.
-12.9%
0.6%
424.9381.4377.1643.2372.8411.9368.2407.7428.1
Bonus Equity Share Capital Ann.
0%
0%
1.81.81.81.81.81.81.81.81.81.81.8
Non Current Investments Unquoted Book Value Ann.
0%
0%
0.30.30.30.30.30.32.62.5344.9344.9394.7
Current Investments Unquoted Book Value Ann.
-
-
*All financials are in INR Cr and price data in INR
Total Assets Ann.
1Y CHG
-2%
2Y CAGR
6.4%
3Y CAGR
5.6%
5Y CAGR
1.5%
7Y CAGR
-7.2%
10Y CAGR
-7.2%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-18.8%
2Y CAGR
7%
3Y CAGR
4.1%
5Y CAGR
7.3%
7Y CAGR
-15.4%
10Y CAGR
-5%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-12%
2Y CAGR
-8.3%
3Y CAGR
-5.2%
5Y CAGR
-11.7%
7Y CAGR
-6.4%
10Y CAGR
-6.9%
Total ShareHolders Funds Annual is falling faster than historical averages.

Panacea Biotec ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

  • NEGATIVE

    Book Value Per Share Panacea Biotec Mar-2026 Book Value Per Share is 43 Rs which is growth of -9.8% YoY.

  • POSITIVE

    ROE Panacea Biotec Mar-2026 ROE is -11% which is growth of 6.1% YoY.

Panacea Biotec Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
BVSH Ann.
-4.6%
-11.5%
4347.750.249.664.279.4142.266.861.872.985.4
RoA Ann. %
-
-
-3.50%-1.75%0.47%-12.09%-12.28%-1.82%-13.44%1.84%-4.29%-4.07%0.04%
ROE Ann. %
-
-
-11.34%-5.20%1.15%-28.79%-23.78%-2.96%-17.57%6.49%-18.99%-16.28%0.16%
ROCE Ann. %
-
-
-3.27%-2.04%3.56%-11.18%-16.79%-0.90%-6.01%-33.81%-2.96%4.78%5.00%
⌄
           
⌄
           
⌄
           
Total Debt to Total Equity Ann.
49.4%
58.5%
10.80.40.30.20.10.10.422.11.9
*All financials are in INR Cr and price data in INR
Current Ratio Ann.
1Y CHG
25%
2Y CAGR
19.5%
3Y CAGR
7.7%
5Y CAGR
-7.8%
10Y CAGR
3.6%
Current Ratio Annual growth is higher than historical averages.

Panacea Biotec cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

  • NEGATIVE

    Cash From Operating Activity Panacea Biotec Mar-2026 Cash From Operating Activity is Rs -40 Cr which is growth of -1119.4% YoY.

  • NEGATIVE

    Net Cash Flow Panacea Biotec Mar-2026 Net Cash Flow is Rs -36 Cr which is growth of -208.2% YoY.

Panacea Biotec Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
-
-
-40.23.937.3-10.7-52.738.3-82.9107.2172.1103.897.9
Cash from Investing Act. Ann.
-
-
-18.5-60.6-512.439.5-37.3-18.5-8.3-2.7-17.922.7
Cash from Financing Act. Ann.
35.7%
-
22.590.112.899.8-7.2109.4-98.5-163.7-91.1-128.7
-
-
-36.233.4-0.90.7-3.3-6.380.45.7-5.2-8.1
*All financials are in INR Cr and price data in INR
Cash from Financing Act. Ann.
1Y CHG
-75%
2Y CAGR
32.6%
3Y CAGR
35.7%
Cash from Financing Annual Activity is falling faster than historical averages.

Panacea Biotec investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access